Contact
searchSearch
HMP Global

Pharmacy Learning Network

PharmLaw

News
Executive Order Targets Accelerated Development and Access Pathways for Psychedelic Therapies in Mental Health
04/21/2026
Hannah Musick
A new executive order directs federal agencies to accelerate the development, review, and potential patient access to investigational psychedelic therapies for serious mental illness, signaling a shift in regulatory and research priorities...
A new executive order directs federal agencies to accelerate the development, review, and potential patient access to investigational psychedelic therapies for serious mental illness, signaling a shift in regulatory and research priorities...
A new executive order directs...
04/21/2026
Pharmacy Learning Network
PharmLaw
CMS Proposes Sweeping Prior Authorization Reforms for Drugs, Expanding Transparency and Electronic Requirements
04/15/2026
Hannah Musick
The Centers for Medicare & Medicaid Services has proposed sweeping reforms to modernize prior authorization for drugs, introducing faster decision timelines, expanded electronic requirements, and new transparency measures that could...
The Centers for Medicare & Medicaid Services has proposed sweeping reforms to modernize prior authorization for drugs, introducing faster decision timelines, expanded electronic requirements, and new transparency measures that could...
The Centers for Medicare &...
04/15/2026
Pharmacy Learning Network
PharmLaw
DOJ Targets Over $500 Million in Health Care and COVID-19 Fraud Schemes Across Multiple Enforcement Actions
04/08/2026
Hannah Musick
The US Department of Justice (DOJ) has launched sweeping enforcement actions targeting over $500 million in alleged fraud across Affordable Care Act (ACA) enrollment, Medicaid drug billing, and COVID-19 relief programs, highlighting...
The US Department of Justice (DOJ) has launched sweeping enforcement actions targeting over $500 million in alleged fraud across Affordable Care Act (ACA) enrollment, Medicaid drug billing, and COVID-19 relief programs, highlighting...
The US Department of Justice...
04/08/2026
Pharmacy Learning Network
PharmLaw
FTC Pauses Adjudication Against Caremark as Parties Pursue Consent Agreement in PBM Case
03/25/2026
Hannah Musick
The Federal Trade Commission (FTC) has paused its case against Caremark to consider a proposed settlement, signaling a potential early resolution in its broader enforcement action against pharmacy benefit managers (PBMs) while litigation...
The Federal Trade Commission (FTC) has paused its case against Caremark to consider a proposed settlement, signaling a potential early resolution in its broader enforcement action against pharmacy benefit managers (PBMs) while litigation...
The Federal Trade Commission...
03/25/2026
Pharmacy Learning Network
PharmLaw
Wholesale Pharmaceutical Executives Sentenced in $92 Million Drug Diversion Scheme
03/18/2026
Grace Taylor, MS, MA
Two wholesale pharmaceutical executives were sentenced in a large-scale drug diversion case that raised concerns about medication safety and supply chain integrity.
Two wholesale pharmaceutical executives were sentenced in a large-scale drug diversion case that raised concerns about medication safety and supply chain integrity.
Two wholesale pharmaceutical...
03/18/2026
Pharmacy Learning Network

FDA Recalls

News
Albuterol Sulfate Inhalation Solution Recalled for Illegible Labeling
04/16/2026
Hannah Musick
The US Food and Drug Administration (FDA) has issued a Class II recall for albuterol sulfate inhalation solution due to illegible labeling, affecting more than 146 000 unit-dose vials used in respiratory care.
The US Food and Drug Administration (FDA) has issued a Class II recall for albuterol sulfate inhalation solution due to illegible labeling, affecting more than 146 000 unit-dose vials used in respiratory care.
The US Food and Drug...
04/16/2026
Pharmacy Learning Network
News
Epinephrine Injection Recalled for Lack of Sterility Assurance
04/16/2026
Hannah Musick
The US Food and Drug Administration (FDA) has issued a Class II recall for epinephrine injection due to sterility assurance concerns, affecting more than 80 000 units used in emergency care settings.
The US Food and Drug Administration (FDA) has issued a Class II recall for epinephrine injection due to sterility assurance concerns, affecting more than 80 000 units used in emergency care settings.
The US Food and Drug...
04/16/2026
Pharmacy Learning Network
News
Cipla Cinacalcet Tablets Recalled for Nitrosamine Impurity Above Acceptable Limits
04/16/2026
Hannah Musick
The US Food and Drug Administration (FDA) has issued a Class II recall for multiple strengths of Cipla’s cinacalcet tablets due to nitrosamine impurity levels exceeding safety limits, raising concerns for long-term use in dialysis patients.
The US Food and Drug Administration (FDA) has issued a Class II recall for multiple strengths of Cipla’s cinacalcet tablets due to nitrosamine impurity levels exceeding safety limits, raising concerns for long-term use in dialysis patients.
The US Food and Drug...
04/16/2026
Pharmacy Learning Network
News
Xanax XR Tablets Recalled for Dissolution Failure
04/09/2026
Hannah Musick
The US Food and Drug Administration (FDA) has issued a Class II recall for Xanax XR tablets after testing revealed failed dissolution specifications, potentially affecting consistent drug release in patients treated for panic disorder.
The US Food and Drug Administration (FDA) has issued a Class II recall for Xanax XR tablets after testing revealed failed dissolution specifications, potentially affecting consistent drug release in patients treated for panic disorder.
The US Food and Drug...
04/09/2026
Pharmacy Learning Network
News
Cipla Lanreotide Injection Recalled for Lack of Sterility Assurance
04/09/2026
Hannah Musick
A Class II recall is in effect for Cipla’s lanreotide injection prefilled syringes due to sterility assurance concerns tied to manufacturing inspection deficiencies.
A Class II recall is in effect for Cipla’s lanreotide injection prefilled syringes due to sterility assurance concerns tied to manufacturing inspection deficiencies.
A Class II recall is in effect...
04/09/2026
Pharmacy Learning Network

In the News

News
Executive Order Targets Accelerated Development and Access Pathways for Psychedelic Therapies in Mental Health
04/21/2026
Hannah Musick
A new executive order directs federal agencies to accelerate the development, review, and potential patient access to investigational psychedelic therapies for serious mental illness, signaling a shift in regulatory and research priorities...
A new executive order directs federal agencies to accelerate the development, review, and potential patient access to investigational psychedelic therapies for serious mental illness, signaling a shift in regulatory and research priorities...
A new executive order directs...
04/21/2026
Pharmacy Learning Network
News
Albuterol Sulfate Inhalation Solution Recalled for Illegible Labeling
04/16/2026
Hannah Musick
The US Food and Drug Administration (FDA) has issued a Class II recall for albuterol sulfate inhalation solution due to illegible labeling, affecting more than 146 000 unit-dose vials used in respiratory care.
The US Food and Drug Administration (FDA) has issued a Class II recall for albuterol sulfate inhalation solution due to illegible labeling, affecting more than 146 000 unit-dose vials used in respiratory care.
The US Food and Drug...
04/16/2026
Pharmacy Learning Network
News
Epinephrine Injection Recalled for Lack of Sterility Assurance
04/16/2026
Hannah Musick
The US Food and Drug Administration (FDA) has issued a Class II recall for epinephrine injection due to sterility assurance concerns, affecting more than 80 000 units used in emergency care settings.
The US Food and Drug Administration (FDA) has issued a Class II recall for epinephrine injection due to sterility assurance concerns, affecting more than 80 000 units used in emergency care settings.
The US Food and Drug...
04/16/2026
Pharmacy Learning Network
News
Cipla Cinacalcet Tablets Recalled for Nitrosamine Impurity Above Acceptable Limits
04/16/2026
Hannah Musick
The US Food and Drug Administration (FDA) has issued a Class II recall for multiple strengths of Cipla’s cinacalcet tablets due to nitrosamine impurity levels exceeding safety limits, raising concerns for long-term use in dialysis patients.
The US Food and Drug Administration (FDA) has issued a Class II recall for multiple strengths of Cipla’s cinacalcet tablets due to nitrosamine impurity levels exceeding safety limits, raising concerns for long-term use in dialysis patients.
The US Food and Drug...
04/16/2026
Pharmacy Learning Network
PharmLaw
CMS Proposes Sweeping Prior Authorization Reforms for Drugs, Expanding Transparency and Electronic Requirements
04/15/2026
Hannah Musick
The Centers for Medicare & Medicaid Services has proposed sweeping reforms to modernize prior authorization for drugs, introducing faster decision timelines, expanded electronic requirements, and new transparency measures that could...
The Centers for Medicare & Medicaid Services has proposed sweeping reforms to modernize prior authorization for drugs, introducing faster decision timelines, expanded electronic requirements, and new transparency measures that could...
The Centers for Medicare &...
04/15/2026
Pharmacy Learning Network

Subscribe Today

Pharmacy Learning Network Newsletter

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use